Erlotero 150mg Tablet
By Erlotero
Rx
30 Tablet in a Strip

Composition
Erlotinib(150mg)

Manufacturer - Hetero Drugs Ltd
7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad – 500 018. Telangana, INDIA

Expires on or after
April, 2026

liver
When it comes to using Erlotero 150mg Tablet for patients with liver disease, caution is advised. It is important to consult with your doctor before starting treatment with this medication. Some patients with liver disease may require a dose adjustment when taking Erlotero 150mg Tablet. While limited information is available on the use of this tablet in patients with liver issues, it is noted that no dose adjustment is generally recommended for those with mild to moderate liver disease. Always seek guidance from your healthcare provider to ensure the safe and appropriate use of Erlotero 150mg Tablet.

kidney
Erlotero 150mg Tablet is safe for patients with kidney disease. No dose adjustment needed. Not recommended for those with severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Erlotero 150mg Tablet.

driving
It is not clear if Erlotero 150mg Tablet affects driving ability. Avoid driving if you notice any symptoms that impact focus or reaction time.

pregnancy
Erlotero 150mg Tablet is not safe to use during pregnancy due to the risk it poses to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Erlotero 150mg Tablet may not be safe during breastfeeding, as there is a risk of the drug passing into breastmilk and potentially harming the baby. It is recommended to consult a doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Quinazoline Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹9900
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025